Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6Other 1

Conditions

Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1

Interventions

Psychiatric Rehabilitation 3Counseling 3Sildenafil Citrate 2Radiotherapy 2High-Intensity Focused Ultrasound Ablation 2Diet Therapy 2Bariatric Surgery 2polyethylene glycol 3350 1methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1bicalutamide 1Weight Reduction Programs 1Testosterone 1Tadalafil 1Robotic Surgical Procedures 1Restraint, Physical 1Radiosurgery 1Prostatectomy 1Phentolamine 1Papaverine 1Observation 1Methods 1Menogaril 1Mammography 1Magnetic Resonance Spectroscopy 1Leuprolide 1Goserelin 1Gonadotropin-Releasing Hormone 1Flutamide 1Finasteride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Tadalafil × Other × Clear all
NCT00931528 2018-02-14

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
242 enrolled 13 charts
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡